Literature DB >> 4590646

Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.

S J Brooks, J M Lyons, A I Braude.   

Abstract

Vaccination with heat-killed or formalinized cells of E coli 0:111, or E coli 06 (Williams), prevented retrograde E coli pyelonephritis. Since there was no bacteremia and no urinary antibody, the vaccination appeared to protect by immune reactions operating in the kidney itself. The vaccine failed to protect against a highly virulent form of E coli 06 (Riffle), possibly because the amount of antibody to its lipopolysaccharide was inadequate. Since all three strains possessed K antigen in approximately equal amounts, the difference in results was not attributed to its presence.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4590646      PMCID: PMC1910770     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  THE IMMUNOLOGIC STATUS OF THE HOST AND PYELONEPHRITIS: A STUDY OF RETROGRADE ESCHERICHIA COLI URINARY INFECTION IN RATS.

Authors:  J A ARANA; V M KOZIJ; G G JACKSON
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

2.  Effects of antibiotics and vaccination on experimental pyelonephritis.

Authors:  H M WEYRAUCH; M L ROSENBERG; A D AMAR; M REDOR
Journal:  J Urol       Date:  1957-11       Impact factor: 7.450

3.  Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.

Authors:  B Kaijser; S Olling
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  The role of antibody in experimental pyelonephritis.

Authors:  M Kyriakos; N S Ikari
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

5.  The effect of urine osmolality and pH on the bactericidal activity of plasma.

Authors:  H Acquatella; P J Little; H E de Wardener; J C Coleman
Journal:  Clin Sci       Date:  1967-12       Impact factor: 6.124

6.  Effect of renal physico-chemical milieu on serum bactericidal activity.

Authors:  E G Hubert; J Z Montgomerie; G M Kalmanson; L B Guze
Journal:  Am J Med Sci       Date:  1967-02       Impact factor: 2.378

7.  Bacteremia in the pathogenesis of retrograde E. coli pyelonephritis in the rat.

Authors:  J Fierer; L Talner; A I Braude
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

8.  The effect of high doses of x-irradiation on the phagocytic, proliferative, and metabolic properties of the reticulo-endothelial system.

Authors:  B BENACERRAF; E KIVY-ROSENBERG; M M SEBESTYEN; B W ZWEIFACH
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

9.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

10.  THE ROLE OF IMMUNITY IN THE PATHOGENESIS OF EXPERIMENTAL RETROGRADE PYELONEPHRITIS.

Authors:  B W HUNTER; L L AKINS; J P SANFORD
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  9 in total

1.  Urinary antibody response after immunisation with a vaccine against urinary tract infection.

Authors:  D Kruze; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1989

2.  Protection by a polyvalent vaccine against challenge infection and pyelonephritis.

Authors:  D Kruze; K Biro; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1992

3.  Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.

Authors:  P R Meylan; M Markert; J Bille; M P Glauser
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

Authors:  P R Meylan; G Braoudakis; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

6.  Antigen presentation as a factor in the protective immune response to renal infection.

Authors:  T E Miller; S Burnham
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

Review 7.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

8.  Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.

Authors:  B Kaijser; P Larsson; S Olling; R Schneerson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.